BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Precision Microbiome Engineering Research - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Precision Microbiome Engineering Research
X-ORIGINAL-URL:https://premier-microbiome.org
X-WR-CALDESC:Events for Precision Microbiome Engineering Research
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241031T120000
DTEND;TZID=America/New_York:20241031T130000
DTSTAMP:20260410T004725
CREATED:20240822T104109Z
LAST-MODIFIED:20240822T104109Z
UID:2573-1730376000-1730379600@premier-microbiome.org
SUMMARY:PreMiEr Fall 2024 Seminar Series | Speaker Dr. Paul Turner
DESCRIPTION:The NSF Engineering Research Center for Precision Microbiome Engineering (PreMiEr) invites you to the next installment of the PreMiEr Fall 2024 Seminar Series on October 31st from Noon to 1pm on Zoom: \nSpeaker: Dr. Paul Turner\n\nLeveraging evolutionary trade-offs in the development of phage therapy\n\nThe rise of antibiotic resistance warrants exploration of novel approaches to target and kill bacterial pathogens. Phage therapy offers a possible alternative\, but a downside is the ability for target bacteria to evolve phage resistance. I develop phages that steer evolutionary ‘trade-offs’: these viruses bind to virulence factors of target bacteria to select for phage-resistance that compromises the function of structures responsible for bacterial pathogenicity. This approach is demonstrated in personalized medicine\, where phage ‘steering’ in patients provides clinical benefits\, such as changing the infecting bacteria to become re-sensitized to chemical antibiotics and decreasing their ability to cause tissue inflammation. \nThis series is open to the public\, but non-PreMiEr members must register to receive the Zoom link. You need register only once for the entire series. \nRegister at https://duke.qualtrics.com/jfe/form/SV_0Pzn6Zv6XjNwKlE
URL:https://premier-microbiome.org/event/2573/
END:VEVENT
END:VCALENDAR